Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

According to Deputy Director, Alexander Bothmann, of Enterprise Florida Inc., in Germany, the 'Sunshine State' is: "Committed to building a world-class biotechnology sector by investing in research facilities, fostering the growth of local biotech companies and welcoming progressive newcomers, such as the Scripps Research Institute, the Burnham Institute for Medical Research and Torrey Pines Institute for Molecular Studies."

Florida

Charlie Martin is a general manager at Leistritz North America

The author describes the benefits, processes, and practicality of using hot-melt extrusion to mix active pharmaceutical ingredients with pharmaceutical-grade polymers.

Continuous Mixing of Solid Dosage Forms via Hot-Melt Extrusion

The use of PVA copolymer-based film can solve the problems associated with lack of film adhesion... to tablets containing large amounts of waxy excipient or a lubricant.

PVA copolymer: the new coating agent

...an uninformed decision based on commercial requirements alone may, ultimately, have disastrous consequences on the efficacy of the target recombinants.

Successful strategies for product optimization

FDA has issued a Final Rule titled "Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals."

FDA Takes "First Step" in Modernizing CGMPs

USP announced an interim revision to its monograph for levothyroxine sodium tablets, which will become official in USP 32-NF 27.

USP Revises Potency Spec for Levothyroxine Sodium Tablets

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Sterile manufacturing may be the next aspect of pharmaceutical manufacturing to consider in the continuous process paradigm.

The Potential of Continuous Sterile Manufacturing

Sylvain Fleury is chief scientific officer at Mymetics.

With economics and politics in the way, can we defeat the malaria epidemic before it defeats us?

Global Warming Heats Up Need for Malaria Vaccine

The author explains the planning, equipment, and facility design requried for manufacturing HPAPIs and specialized requirements for handling these compounds.

High-Potency APIs: Containment and Handling Issues

We have to make the politicians understand that if we don't take biotech seriously then tourism will be our premier industry in the future.